Rx/Reimbursement Adult Incontinence in the Netherlands

  • ID: 4517581
  • Report
  • Region: Netherlands, Holland
  • 15 pages
  • Euromonitor International
1 of 4
Faced with an increasingly ageing population, the Dutch government is trying to contain the largely increasing healthcare bill each year. This means looking for efficient ways to deliver healthcare but at the same time maintaining health delivery of reasonable quality. As it is not life threatening, adult incontinence is considered secondary and is susceptible to major overhauls to make it efficient and less costly. As a result, the number of users in 2017 declined again, affecting both volumes...

The publisher's Rx/Reimbursement adult incontinence in Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2013-2017, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2022 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Rx/Reimbursement adult incontinence market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
2 of 4
Rx/Reimbursement Adult Incontinence In The Czech Republic

Headlines

Prospects

Rx/Reimbursement Adult Incontinence System
Value Sales Of Rx/Reimbursement Adult Incontinence Drop Under Vzp's New Policy
Tena Continues To Dominate

Category Data
Table 1 Sales Of Rx/Reimbursement Adult Incontinence: Total Value Msp 2012-2017
Table 2 Sales Of Rx/Reimbursement Adult Incontinence: Total Value Msp Growth 2012-2017
Table 3 Forecast Sales Of Rx/Reimbursement Adult Incontinence: Total Value Msp 2017-2022
Table 4 Forecast Sales Of Rx/Reimbursement Adult Incontinence: Total Value Msp Growth 2017-2022
Executive Summary
Tissue And Hygiene's Good Performance Continues In 2017
Czech Consumers Purchase More Premium Variants And Larger Packs During 2017
Multinationals Lead Among Branded Players, But Private Label Holds The Biggest Share
Hypermarkets Leads And Internet Retailing Sees Further Growth
Anticipated Positive Growth For Both Retail And Away-From-Home Tissue And Hygiene

Market Indicators
Table 5 Birth Rates 2012-2017
Table 6 Infant Population 2012-2017
Table 7 Female Population By Age 2012-2017
Table 8 Total Population By Age 2012-2017
Table 9 Households 2012-2017
Table 10 Forecast Infant Population 2017-2022
Table 11 Forecast Female Population By Age 2017-2022
Table 12 Forecast Total Population By Age 2017-2022
Table 13 Forecast Households 2017-2022

Market Data
Table 14 Retail Sales Of Tissue And Hygiene By Category: Value 2012-2017
Table 15 Retail Sales Of Tissue And Hygiene By Category: % Value Growth 2012-2017
Table 16 Nbo Company Shares Of Retail Tissue And Hygiene: % Value 2013-2017
Table 17 Lbn Brand Shares Of Retail Tissue And Hygiene: % Value 2014-2017
Table 18 Penetration Of Private Label In Retail Tissue And Hygiene By Category: % Value 2012-2017
Table 19 Distribution Of Retail Tissue And Hygiene By Format: % Value 2012-2017
Table 20 Distribution Of Retail Tissue And Hygiene By Format And Category: % Value 2017
Table 21 Forecast Retail Sales Of Tissue And Hygiene By Category: Value 2017-2022
Table 22 Forecast Retail Sales Of Tissue And Hygiene By Category: % Value Growth 2017-2022
Definitions
Sources
Summary 1 Research Sources
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll